IGFBP-7 to confer resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.

e20572Background: Lung cancer is a leading cause of cancer death worldwide. The EGFR mutation-positive patients of lung adenocarcinoma had dramatic response to EGFR tyrosine kinase inhibitors (TKIs...